Bayer to slash 12,000 jobs after Monsanto takeover Medical Dialogues Bureau30 Nov 2018 9:00 AM ISTBERLIN: German chemical and pharmaceutical giant Bayer said Thursday it would slash 12,000 jobs in a major restructuring following the mammoth...
Loxo,Bayer gets U.S approval for cancer drug Larotrectinib Medical Dialogues Bureau28 Nov 2018 9:06 AM ISTNew Delhi: A Loxo Oncology Inc drug larotrectinib shown to be effective against a wide variety of cancers driven by a single, rare genetic mutation...
Pfizer lowers revenue forecast on strong dollar, supply issues Medical Dialogues Bureau31 Oct 2018 5:15 PM ISTU.S. drugmaker Pfizer Inc cut the top end of its full-year revenue forecast range on Tuesday, citing a stronger dollar and lower revenue from its...
USFDA approves Mylan, Biocon's Fulphila, the first biosimilar to Neulasta Ruby Khatun Khatun6 Jun 2018 10:30 AM ISTHERTFORDSHIRE/PITTSBURGH and BENGALURU: Mylan N.V. and Biocon Ltd. announced that the U.S. Food and Drug Administration (FDA) has approved Mylan's...
Two Common Health Risks Early Preparation Can Save You From Ruby Khatun Khatun10 March 2018 3:43 PM ISTAs you age, the risks of health problems (including diabetes, cancer, cardiovascular and lung disease) increase and can prevent you from enjoying your...
Bumper crop of new drugs fails to lift big pharma Research and Development returns Ruby Khatun Khatun16 Dec 2017 9:45 AM ISTLONDON: It is shaping up to be a bumper year for drug approvals, with U.S. officials clearing twice as many novel medicines as in 2016, yet returns on...
Novartis CAR-T therapy leads to durable response in lymphoma study Ruby Khatun Khatun11 Dec 2017 10:45 AM ISTPatients with an advanced form of an aggressive blood cancer who had initially responded to Novartis' new type of gene-modifying immunotherapy...
More than 2,000 drugs now in cancer immunotherapy race Ruby Khatun Khatun9 Dec 2017 10:00 AM ISTLONDON: The race to develop new immunotherapy treatments against cancer has sparked an unprecedented explosion in the oncology drug pipeline, with...
Roche's Foundation Medicine wins FDA approval for new cancer test Ruby Khatun Khatun6 Dec 2017 9:30 AM ISTZURICH: Roche on Monday said its Foundation Medicine unit won U.S. Food and Drug Administration (FDA) approval for a test to help doctors understand...
Panacea Biotec gets USFDA nod to file for generic cancer drug Ruby Khatun Khatun2 Dec 2017 10:00 AM ISTNew Delhi: Panacea Biotec said the US health regulator has accepted its filing for approval of generic version of cancer treatment injection...
Merck KGaA, Pfizer's immunotherapy fails in gastric cancer trial Ruby Khatun Khatun1 Dec 2017 9:30 AM ISTFRANKFURT: Germany's Merck KGaA has suffered a setback in the development of key cancer immunotherapy Bavencio, it has failed in a trial to prolong...
Cancer, cardiac among 51 essential drugs under NPPA price cap, check out details Ruby Khatun Khatun24 Nov 2017 4:15 PM ISTNew Delhi: National drug pricing regulator NPPA on Friday said it has capped prices of 51 essential formulations, including those used for the...
